Oruka Therapeutics (ORKA) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | -36.36% |
| Sep 30, 2025 | 191.18% |
| Jun 30, 2025 | 161.54% |
| Mar 31, 2025 | -27.78% |
| Mar 31, 2022 | -71.43% |
| Dec 31, 2021 | -75.00% |
| Sep 30, 2021 | 460.00% |
| Jun 30, 2021 | 66.67% |
| Mar 31, 2021 | -76.92% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 50.00% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2016 | -33.33% |
| Sep 30, 2016 | 500.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | -50.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | -60.00% |
| Jun 30, 2015 | 150.00% |
| Mar 31, 2015 | -85.71% |
| Dec 31, 2013 | -63.64% |
| Sep 30, 2013 | 37.50% |
| Jun 30, 2013 | -11.11% |
| Mar 31, 2011 | -50.00% |